Standout Papers

Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Canc... 2003 2026 2010 2018 557
  1. Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer (2007)
    Stephen A. Cannistra, Ursula A. Matulonis et al. Journal of Clinical Oncology
  2. Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer (2005)
    Herbert I. Hurwitz, Louis Fehrenbacher et al. Journal of Clinical Oncology
  3. Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism (2003)
    Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine
  4. Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer (2005)
    Fairooz F. Kabbinavar, Julie Hambleton et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 77 standout
Sub-graph 1 of 16

Citing Papers

Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Venous thromboembolism
2021 Standout
53 intermediate papers

Works of Julie Hambleton being referenced

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
2008
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
2003 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Julie Hambleton 454 645 652 1127 31 3.0k
W M Hryniuk 395 270 223 1886 33 3.2k
Edward P. Balaban 465 1445 2118 961 36 3.6k
H. Anderson 139 237 184 1400 51 2.7k
Xiaolei Zhu 154 612 231 816 34 2.0k
D C Tormey 192 201 182 2085 54 3.5k
Ingvar Syk 137 274 173 1230 85 2.5k
David Trent 184 402 617 1447 27 3.7k
Maddalena Barba 225 818 1224 894 117 3.2k
H.J. Keizer 227 184 77 656 61 2.2k
Simon L. Parsons 101 144 138 822 57 2.7k

All Works

Loading papers...

Rankless by CCL
2026